You are here

Introduction

Prof. Axel Ullrich is member of the Board of Directors at ProteoMed GmbH, Tubungen, Germany. He is also the Honorary Professor at the University of Tubingen.

Prof. Ullrich is ranked as Highly Cited by ISI under the category of Molecular and Gentics Biology, Biochemistry, Microbiology and Clinical Medicine. Prof. Ullrich will be working with King Saud University's Biomarker Research Program with the team of highly qualified professionals on differect research projects in Riyadh, Saudi Arabia.

Professor Axel Ulrich visited Biomarker Research Program on 20/12/1430, corresponding to 7/12/2009, and gave a lecture entitled 30Years of Gene Based Molecular Medicine.

Activities

Professor Axel Ulrich visited Biomarker Research Program on 20/12/1430, corresponding to 7/12/2009, and gave a lecture entitled 30Years of Gene Based Molecular Medicine.

Appointments & Affiliations

 

Dates

Title

Organization

City, State/ Province

Country

2000-Present

Board of Directors

ProteoMed GmbH

Tubingen

Germany

2000

Honorary Professor

University of Tubingen

Tubingen

Germany

1999-Present

Co-Chairman Clinical Science Advisory Board

SUGEN, Incorporated/
Pharmacia Upjohn

South San Francisco, CA

United States

1999-Present

Board of Directors

BioImage A/S

Soborg

Sweden

1999-Present

Science Advisor

SUGEN, Incorporated/
Pharmacia Upjohn

South San Francisco, CA

United States

1999

Managing Director

Max-Planck-Institut fur Biochemie

Martinsreid

Germany

1998-Present

Consultant and Chief Scientific Advisor

Axxima Pharmaceuticals AG

Martinsreid

Germany

1998

Founder

Axxima Pharmaceutical AG

Martinsreid

Germany

1996-Present

Founder and Vice Chairman of Academic Board

Second Military Medical University/Cooperation Laboratory for Biological Signal Transduction Research

Shanghai

Peoples Rep China

1996-1998

Professor

Sorbonne/Academie de Paris

Paris

France

1996

Honorary Professor

Second Military Medical University

Shanghai

Peoples Rep China

1991-1999

Founder, Consultant and Chief Scientist

SUGEN, Incorporated

Redwood City, CA

United States

1991-1999

Member Board of Directors and Scientific Advisory Board

SUGEN, Incorporated

South San Francisco, CA

United States

1988-Present

Director

Max-Planck-Institut/Department of Molecular Biology

Martinsreid

Germany

1984-1988

Staff Scientist

Genetech, Incorporated

South San Francisco, CA

United States

1979-1984

Senior Scientist

Genetech, Incorporated

South San Francisco, CA

United States

1977-1978

Assistant Research Biochemist

University of California, San Francisco

San Francisco, CA

United States

1975-1977

Postdoctoral Fellowship

Deutsche Forschungsgemeinschaft

Bonn

Germany

1975-1977

Postdoctoral Fellow

University of California, San Francisco/Department of Biochemistry and Biophysics

San Francisco, CA

United States

1972-1974

Fellowship Recipient

University of Heidelberg/

Institute of Molecular Genetics

Heidelberg

Germany

1971-1972

Assistant Biochemist

University of Munster/
Institute of Biochemistry

Munster

Germany

 

Research Interests
 

Molecular Biology; Genetics; Biology;  Biochemistry;  Microbiology; Clinical Medicine

Publications

  Arcaro, A., Zvelebil, M.J., Wallasch, C., Ullrich, A., Waterfield, M.D., Domin, J.. "Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors." Molecular and Cellular Biology 20 3817 - 3830, 2000..

 2000. Bange, J., Prechtel, D., Harbeck, N., Schmitt, M., Cheburkin, Y., Specht, K., Knyazev, P., Knyazeva, T., Gartner, S., Sures, I., Imyanitov, E., Haring, H.U., Iacobelli, S., Hofler, H., Ullrich, A.. Breast Cancer Progression and Tumor Cell Motility are Associated with the FGFR4 Arg388 allele (submitted)..

  Bossenmaier, B., Strack, V., Stoyanov, B., Krutzfeldt, J., Beck, A., Lehmann, R., Kellerer, M., Klein, H., Ullrich, A., Lammers, R., Haring, H.U.. "Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation." Diabetes 49 889 - 895, 2000..

  2000. Buchler, P., Reber, H.A., Buchler, M., Beger, H.G., Ullrich, A., Buchler, M.W., Friess, H., Lavey, R.S., Hines, O.J.. Inhibition of Pancreatic Cancer Growth by a Dominant Negative VEGF-R2 Mutant (submitted)..

 2000. Hackel, P.O., Gishitzky, M., Ullrich, A.. Mig-6 is a Negative Regulator of the Epidermal Growth Factor Receptor Signal (submitted)..

View More Publications

Contact Information
Abteilung Molekularbiologie

Max-Planck-Institut für Biochemie

Am Klopferspitz 18

Martinsried, D-82152, Germany

Telephone:

+49 89 85782512

Fax Number:

+49 89 8577866

E-mail:

ullrich@biochem.mpg.de

URL: https://biomarker.ksu.edu.sa/en/prof-axel-ullrich